Click to sign-up for email updates.
CytomX Therapeutics, Inc. – Severance and Change of Control Agreement (March 2nd, 2017) This Severance and Change of Control Agreement (the "Agreement") is made and entered into, effective as of March 23, 2016 (the "Effective Date"), by and between CytomX Therapeutics, Inc. a Delaware corporation (the "Company"), and Michael Kavanaugh, Senior Vice President, Chief Scientific Officer ("Employee").
This Severance and Change of Control Agreement (the "Agreement") is made and entered into, effective as of March 23, 2016 (the "Effective Date"), by and between CytomX Therapeutics, Inc. a Delaware corporation (the "Company"), and Michael Kavanaugh, Senior Vice President, Chief Scientific Officer ("Employee").
by using one of this services
or